Igloria, Gino .

HRN: 21-74-72  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2022
CEFUROXIME 750MG (VIAL)
08/04/2022
08/10/2022
IVT
750mg
Q8
Uti, Urti
Waiting Final Action 
08/06/2022
MUPIROCIN 2%, 15G (TUBE)
08/06/2022
08/12/2022
TOPICAL
Apply Thinly
Q12
Bacterial Skin Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: